NCT06216002 Incidence of Residual Neuromuscular Blockade in Fraility in OncoGynae Surgery
| NCT ID | NCT06216002 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mahidol University |
| Condition | Frailty |
| Study Type | INTERVENTIONAL |
| Enrollment | 622 participants |
| Start Date | 2024-01-02 |
| Primary Completion | 2025-12-31 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
Frailty among patients undergoing surgery is strongly associated with an elevated risk of adverse perioperative outcomes, heightened incidence of postoperative complications, increased mortality rates, and prolonged hospital length of stay. Our focus centers on investigating the frailty index in the context of complications experienced by patients undergoing oncologic gynecology surgery. The principal objective of this research is to elucidate the extent to which residual neuromuscular blocking agents are linked to frailty.
Eligibility Criteria
Inclusion Criteria: * Age \>,= 18 years * Patients undergoing elective gynecologic-oncology surgery Exclusion Criteria: * Unable to communicate Thai * Unable to understand the questionnaire * Preexisting neuromuscular disease * Preexisting disease involved wrist that may affect the nerve stimulator examination